Curriculum Vitae. Lone Cleveland Andersen. Courses
|
|
- Paulina Norton
- 5 years ago
- Views:
Transcription
1 Courses and continuing education, listed by subjects. GMP courses API Curriculum Vitae Lone Cleveland Andersen Courses ICH Q7; Compliance for API s manufactured by cell culturing and fermentation, European Compliance Academy, Copenhagen, 2 days API handling and inspections, DHMA, 1 day Active Pharmaceutical Ingredients, Daniel Gold, Novo Nordisk A/S, 2 days Aseptic production Risk Management of Aseptic / terminally sterilized production, IFF Copenhagen, 1 day (2015) Understanding Pharmaceutical Sterilization, Compliance & Validations Services Ltd.; Amsterdam, 3 days. Environmental Monitoring, European Compliance Academy, Copenhagen, 2 days Seminar re. Millipore filters, DHMA, 1 day Freeze-drying equipment and processes, Scantago and DHMA, 1 day Theme; clean rooms, Dansk Standard and DHMA, 1 day Monitoring clean rooms, Holm & Halby and DHMA, 1 day Physical particle characterization, Particle Analytical and DHMA, 1 day Aseptic production, Novo Nordisk A/S, 1 day Validation of clean rooms, Novo Nordisk A/S, 1 day Practical microbiology, Novo Nordisk, 2 days Millipore filters, Novo Nordisk, 1 day FDA and European GMP Compliance for cleanrooms and how the best to meet it, European Compliance Academy, Copenhagen, 2 days Manufacturing and validation of sterile medicine, Pharmakon, Hilleroed, 3 days Audit and contract manufacturing Contract manufacturing, Pharmakon, Hilleroed, 1 day Internal audits and quality audits, Pharmakon, Hilleroed, 2 days GMP Compliance Auditing, John Lee, Novo Nordisk A/S, 2 days Batch records Batch Records Review and Investigation, John Lee, Novo Nordisk A/S, 2 days Biotech and cell cultures Biotechnology for Non-Biotechnologists, European Compliance Academy, Berlin, 2 days ICH Q7; Compliance for API s manufactured by cell culturing and fermentation, European Compliance Academy,2 days GMP compliance for Biopharmaceuticals, API manufacturing, Novo Nordisk A/S, 2 days Active Pharmaceutical Ingredients, Daniel Gold, Novo Nordisk A/S, 1 day 1
2 Change Control Change Control, Novo Nordisk A/S, 1 day Change Control procedure, Novo Nordisk A/S, ½ day Deviations and CAPA Non Conformities Handling, Novo Nordisk A/S, 1 day Introduction to A2DB - non conformity IT database, Novo Nordisk A/S, 1 day General GMP GMP updates 2015, IFF Copenhagen, 1 day (2015) Physical particle characterization, Particle Analytical and DHMA, 1 day Non-sterile Drug Products, GMP Compliance & Education, Copenhagen, 2 days Handling alarms and interventions, Novo Nordisk A/S, 1 day GMP in Global Support, module 1 & 2, Novo Nordisk A/S, 2 days GMP compliance, European Compliance Academy, Copenhagen, 2 days Are your systems in compliance with 21 CFR part 11, Pharmakon, 2 days Safety requirements of physical and IT based batch documentation, Novo Nordisk A/S, 1 day Quality improvements in Production, Conference in London, 2 days GMP og communication, Pharmakon, 3 days Quality Mind-set, Novo Nordisk A/S, 1 day GMP for academics and specialists, Novo Nordisk A/S, 2 days Several professional GMP training days, DHMA, 25 days Inspection GMP Compliance Auditing, John Lee, Novo Nordisk A/S, 2 days Preparing a FDA inspection, John Lee, Novo Nordisk A/S, 2 days FDA Pre- and Post-approval inspections, Pharmakon, 2 days IT systems EU GMP, Annex 11; inspection of computer systems, DHMA, 1 day Computer Validation: Maintaining Control of Operation, European Compliance Academy, Barcelona, 2 days Diamant, specialized registration system, DHMA, 1 day Training in Diamant system, DHMA, 1 day Diamant pilot training, DHMA, 1 day Guidelines directions for GoPro archive ring system, DHMA, ½ day ISOTrain, Training Coordinator Course, Novo Nordisk A/S, 1 day COCPIT; handling and register of customer complaints, Novo Nordisk A/S, 1 day QBIQ; main use of UserAR2 database, Novo Nordisk A/S, 1 day Introduction to DBEIS System, internal IT, Novo Nordisk A/S, 1 day HC*LIMS, Analytical result system, Novo Nordisk, 1 day Introduction to A2DB - non conformity database, Novo Nordisk A/S, 1 day 2
3 Laboratories Latest regulations/guidelines, inspection and enforcement trends for FDA s CFR Part 11 in pharmaceutical laboratories, Agilent Technologies, Copenhagen 1 day Registration Drug / Device Combination Products GMP for combinations product, Pharmakon, 1 day (2015) Regulatory Approval of medicine (authorities), DHMA, 1 day Approval of drugs, Pharmakon, 1 day Costumer Complaints Handling of Costumer Complaints in COCPIT IT system, Novo Nordisk A/S, 1 day Risk Management Quality Risk Management Part III, Pharmakon Hilleroed, 1 day Risk Management in Sterile Manufacturing, European Compliance Academy, Copenhagen, 2 days Risk and Science based Manufacturing (Powder & tablets), ISPE, Copenhagen, 1 day Excipients and suppliers GMP for Excipients, European Compliance Academy, Copenhagen, 2 days Environmental and social evaluation of Suppliers, Novo Nordisk A/S, 1 day Qualified Person, QP The role of QP, IFF Copenhagen, 1 day (2015) European Compliance Academy, conference: 3rd Annual Qualified Person Forum, München, 2 days European Compliance Academy conference: 2nd Annual Qualified Person Forum 2007, Berlin, 2 days QP networking and experience, Pharma Danmark, ½ day Statistics Introduction to statistics for academics, Novo Nordisk A/S, 2 days Practical statistics for academics, Novo Nordisk A/S, 2 days Main statistics, Novo Nordisk A/S, 1 day Statistics seminar, Novo Nordisk A/S, 2 days Validation FDA s new approach to Process validation, NNE Pharmaplan, 1 dag Quality by Design and Analytical Methods, DHMA, 1 day Cleaning and Cleaning Validation, Compliance & Validations Services Ltd., Amsterdam, 3 days Design Space og PAT, DTU Kemiteknik, 2 days Cleaning Validation, Rebecca Brewer, Novo Nordisk A/S, 2 days Manufacturing and validation of sterile drugs, Pharmakon, 3 days 3
4 GDP GDP latest news New Guidance, Pharmakon Hilleroed, 1 day Global Supply Chains, PIC/S seminar, Ottawa, 3 days. Training and interpretation of the new GDP guideline, DHMA, 1 day GDP news; new GDP guideline, Pharmakon, 1 day PIC/s seminar; Good Distribution Practise, Krakow, 3 days GCP GMP meets GCP, European Compliance Academy, Copenhagen, 2 days Pharmacovigilance 2012 EU Pharmacovigilance Training Course, Copenhagen, 3 days Pharmacovigilance Inspectors Work Group (PhV IWG) Training, EMA, Antwerp, 3 days PHV IWG meeting in EMA-London, 1 day EMA-London: Training in Pharmacovigilance database Eudravigilance, 1 day Pharmacovigilance introduction, Pharmakon, 1 day QA in Pharmacovigilance Post marketing & Clinical Trials, Pharmakon, 2 days Pharmacovigilance GMP/GCP, DHMA, 1 day Several professional Pharmacovigilance training days, DHMA, 2 days Project Management and Management Project management, module 2, Novo Nordisk A/S, 5 days Project management, module 2, Novo Nordisk A/S, 5 days KREA manager; creative processes for management, Krea Consult, 2 days Advanced Power 2 Influence, module 2; personal development and management, Learn 2 Lead, 4 days Supply Professionals Academy module 1-3, business relations and project management, Novo Nordisk A/S, 6 days Advanced Power 2 Influence module 1; personal development, Learn 2 Lead, 4 days Process planning and mapping of business processes, Force Technology, 2 days Certified Auditor/Lead Auditor examination, BSI Training Service, 5 days Labour legislation for managers, module 1-5, Novo Nordisk A/S, 5 days Blood legislation Serology, Blood bank, Naestved, 2 days HCV, Dansk Transplantationsselskab, ½ day PIC/S seminar Tissues, cell and blood, Copenhagen, 4 days NAT analysis, Henrik Ullum, Rigshospitalet, DHMA, 1 day Several professional training days in blood and tissue, DHMA, 2 days 4
5 ISO DANAK assessor, DS/EN ISO standard for laboratories, 3 days Certified Auditor/Lead Auditor examination, BSI Training Service, 5 days Training for internal auditors, DHMA, 1 day Process planning and mapping of business processes, Force Technology, 2 days Update of DS/EN ISO 9001:2000 standard, Force Technology, 1 day ISO training and preparation for audits, Novo Nordisk A/S, 1 day Introduction to DS/EN ISO 9000, Force Instituttet, 2 days DS/EN ISO 9000 standard, Novo Nordisk A/S, 2 days LEAN clean; LEAN tools, Novo Nordisk A/S, several modules, 6 days clean main course, Novo Nordisk A/S, 1 day (Other courses) Deception, how to cope (police), DHMA, 1 day Conference for staff in DHMA, 1 day Rules for employees in DHMA, 2 days Written communication, DHMA, 1 day Doc2000, Internal IT course, DHMA, 1 day LOS; how to handle internal company information s, DHMA, 1 day Introduction for new employees, DHMA, 1 day The quality system, DHMA, 1 day Unwritten rules of career, DIEU, 2 days Market Awareness French culture, Novo Nordisk A/S, 1 day Market Awareness Japanese, culture, Novo Nordisk A/S, 1 day Market Awareness Brazilian culture, Novo Nordisk A/S, 1 day Market Awareness American culture, Novo Nordisk A/S, 1 day Outlook 2000, Novo Nordisk A/S, 1 day Presentation technique, Novo Nordisk A/S, 1 day Firefighting Novo Nordisk A/S, ½ day Effective communication and collaboration, Teknologisk Institut, 3 days Report writing skills, advanced level, Novo Nordisk A/S, 3 days Internet for pharmaceuticals, Pharmakon, 1 day Word Perfect to Windows 5.2; Novo Nordisk A/S, 1 day Introduction for new employees, Novo Nordisk A/S, 1 day Advanced English, Novo Nordisk A/S, 1 day 5
ISO 13485:2016 MEDICAL DEVICES QMS TRANSITION GUIDE
ISO 13485:2016 MEDICAL DEVICES QMS TRANSITION GUIDE ISO 13485, OVERVIEW ISO 13485 sets regulatory requirements or, when specified, customer requirements for a management system for medical devices or services.
More informationValidation Introduction. Presented by John Montalto 27 March, 2013
Validation Introduction Presented by John Montalto 27 March, 2013 John Montalto Bachelor of Science Management Diploma >15 years of Industry Experience Consultant to United Nations various Government Regulatory
More informationCurriculum Vitae. Jeppe Kjems. Summary
Curriculum Vitae Jeppe Kjems Position: Owner, CU-Engineering Education: ETM, Engineering Technology Management, 2000, M.Sc., Dairy Engineering, 1986 Year of birth: 1958 Languages: Danish, English, Portuguese,
More informationSTERILITY TESTING OF PHARMACEUTICAL PRODUCTS
STERILITY TESTING OF PHARMACEUTICAL PRODUCTS Tim Sandle CONTENTS Introduction xiii 1 STERILITY 1 Introduction 1 Sterility 3 Microorganisms and Microbial Growth 5 Types of microorganisms 7 Sterilization
More informationSingle market, regulatory environment, industries under vertical legislation Pharmaceuticals : regulatory framework and market authorisations
EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals : regulatory framework and market authorisations Brussels,
More informationDeviations Inspection Observations & Issues to Consider for Achieving Compliance
Deviations Inspection Observations & Issues to Consider for Achieving Compliance Kevin O Donnell, Ph.D. Market Compliance Manager Irish Medicines Board IMB GMP & Market Compliance Information Day Dublin,
More informationQuality, Safety and Sourcing in Unlicensed Medicines
Quality, Safety and Sourcing in Unlicensed Medicines with Andrew Trouton Managing Director, UL Medicines Agenda Welcome What is an unlicensed medicine? When should you consider using an unlicensed medicine?
More informationCooperation between HALMED and GMP Inspectorate in supervision of manufacturers: Croatia s experience so far
Cooperation between HALMED and GMP Inspectorate in supervision of manufacturers: Croatia s experience so far Ana Boban, MPharm. Agency for Medicinal Product and Medical Devices of Croatia Dubrovnik, 06.05.2013.
More informationINTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL
More informationCalendar of Events. 1 2 June 2006 RAPS 2006 European Conference: EU Regulatory Response to Innovation and Global Competitiveness
Calendar of Events 31 May 2 June 2006 The Validation Manager Venue: Vienna, Austria. 1 2 June 2006 RAPS 2006 European Conference: EU Regulatory Response to Innovation and Global Competitiveness Venue:
More informationExcipient Risk Assessment
Excipient Risk Assessment Richard O Sullivan- GMP Inspector GMP Conference 7 February 2017 Dublin Content Background 1 Guidance 2 HPRA Expectations 3 07/02/2017 2 Excipient Risk Assessment-Why? 07/02/2017
More informationEU Regulatory Update & GMP Deficiencies. Bryan J Wright July 2017
EU Regulatory Update & GMP Deficiencies Bryan J Wright July 2017 Slide 1 PharmOut 2017 Outline Update on changes in EU GMP Guide Summary of GMP changes to the Guide Important details of changes over the
More information2008 Public Status Report on the Implementation of the European Risk Management Strategy. Executive Summary
European Medicines Agency London, 17 March 2009 Doc. Ref. EMEA/43556/2009 2008 Status Report on the Implementation of the European Risk Management Strategy Executive Summary The European Risk Management
More informationUpdate from FDA Office of Regulatory Affairs
Update from FDA Office of Regulatory Affairs Ellen F. Morrison Assistant Commissioner for Medical Products and Tobacco Operations Office of Regulatory Affairs U.S. Food and Drug Administration 1 The Impact
More informationPIC/S GUIDANCE ON CLASSIFICATION OF GMP DEFICIENCIES
PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 040-1 3 Appendices 1 January 2019 PIC/S GUIDANCE ON CLASSIFICATION OF GMP DEFICIENCIES PIC/S January 2019 Reproduction
More informationPDA Points to Consider relating to EU GMP Annex 1 changes. Presented by Ashley Isbel 30 November, 2016
PDA Points to Consider relating to EU GMP Annex 1 changes Presented by Ashley Isbel 30 November, 2016 Lets get interactive! On your smart device, open a browser app and go to the link provided Click on
More informationCDER Compliance Update
CDER Compliance Update Douglas Stearn, JD Deputy Director for Policy and Analysis FDA/CDER/Office of Compliance FDLI Enforcement, Litigation and Compliance Conference Washington, DC December 12, 2012 1
More informationOverview of Generic Drug Policy and Introduction of its Review Points/BE Guideline in Japan
1 5 th Joint Conference of Taiwan and Japan on Medical Products Regulation Overview of Generic Drug Policy and Introduction of its Review Points/BE Guideline in Japan Mr. Yoshihiko Sano Deputy Director,
More informationProcurement policies and requirements
Procurement policies and requirements JOINT UNICEF, UNFPA & WHO meeting with manufacturers, Copenhagen 22-24 Sep 2014 ELODIE JAMBERT International Pharmacist Coordinator Médecins Sans Frontières (MSF)
More informationANSM (France) Inspections in both materiovigilance and pharmacovigilance.
Curriculum vitae PERSONAL INFORMATION Olivier Diby WORK EXPERIENCE November 2015 Present Inspector Inspections in both materiovigilance and pharmacovigilance. November 2009 November 2015 MD, Drug Safety
More informationINTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL
More informationQuality Management System Certification. Understanding Quality Management System (QMS) certification
Quality Management System Certification Understanding Quality Management System (QMS) certification The medical device manufacturing sector is one of the most regulated sectors in which significant quality
More informationParametric Release Regulatory Requirements. Terry E. Munson Technical Vice President PAREXEL International, LLC
Parametric Release Regulatory Requirements Terry E. Munson Technical Vice President History First application approved for parametric release in 1985 Formed the basis for the FDA Compliance Policy Guide
More informationAKA Good Manufacturing Practice (GMP) Certification Program
AKA Good Manufacturing Practice (GMP) Certification Program Preamble The American Kratom Association (AKA) is establishing this program to assure the safety and integrity of kratom dietary supplements
More informationPartner with the Global Leader in Drug Delivery Systems.
3M DRUG DELIVERY SYSTEMS Partner with the Global Leader in Drug Delivery Systems. Hurlingham, Argentina Manufacturing Facility Experts at Commercializing Innovation Drug Delivery Systems: It s in the detail
More informationPartner with the Global Leader in Drug Delivery Systems.
3M DRUG DELIVERY SYSTEMS Partner with the Global Leader in Drug Delivery Systems. Hurlingham, Argentina Manufacturing Facility Experts at Commercializing Innovation 3M is a global innovation company that
More informationBlanka Hirschlerová. EDQM CEP conference Prague, Czech Republic
1 Experience with CEPs from a European regulatory authority perspective Blanka Hirschlerová EDQM CEP conference Prague, Czech Republic 2012 STATE INSTITUTE FOR DRUG CONTROL Agenda 2 Agenda Introduction
More informationPartner with the Global Leader in Drug Delivery Systems
3M DRUG DELIVERY SYSTEMS Partner with the Global Leader in Drug Delivery Systems Loughborough, United Kingdom Manufacturing Facility Experts at Commercializing Innovation 3M: Transforming New Ideas into
More informationMedication errors. Impact of medication error guidance and regulation on drug-device combination products. June 2017 Dan Wozinski
Medication errors Impact of medication error guidance and regulation on drug-device combination products June 2017 Dan Wozinski Agenda Understand the management of medication errors within global requirements
More informationQA Regulatory forum: Classification and Risk assessment according to MDR Date : T h e r e s e. A l b i n s s o m e d q t e c h.
QA Regulatory forum: Classification and Risk assessment according to MDR Date : 05.04.2018 THERESE ALBINSSON T h e r e s e. A l b i n s s o n @ m e d q t e c h. s e MedQtech AB MedQtech AB is a consultant
More informationWHAT DO MANUFACTURERS AND IMPORTERS HAVE TO DO TO PREPARE FOR EU MEMBERSHIP?
WHAT DO MANUFACTURERS AND IMPORTERS HAVE TO DO TO PREPARE FOR EU MEMBERSHIP? pharmaceutical regulatory affairs consulting and education www.rapharm.eu Vesna Koblar, MD. PhD. EU28: Science, Medicines, Health
More informationIPEC Europe Suggested Alternative (if none then original text is clear and needs no alteration) Purpose and Scope
IPEC Europe Observations and Recommendations on Guidelines On The Formalised Risk Assessment For Ascertaining The Appropriate Good Manufacturing Practice For Excipients Of Medicinal Products For Human
More informationOverview Internal review
Overview Internal review Presentation title: QRM, It s not all about the assessment Track title: Day 1, Session 2 Speaker: Seamus Orr Date / Time: 10 August 2015, 14.30 15.00 Time allotted: 30 minutes
More informationINTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL
More informationReview Article ISSN: Open Access. Regulatory Aspects of Pharmaceutical Excipients in India and their Qualification to Use in Pharmaceuticals
Review Article ISSN: 2581-4559 Open Access UPI JOURNAL OF BUSINESS MANAGEMENT AND COMPUTER APPLICATIONS Journal Home Page: https://uniquepubinternational.com/upi-journals/upi-journal-ofbusiness-management-and-computer-applications-upi-jbmca/
More informationHealth Products Regulatory Authority IPAR. Public Assessment Report for a. Traditional Herbal Medicinal Product
IPAR Public Assessment Report for a Traditional Herbal Medicinal Product for Human Use Ginkgo-Biloba Pharma Nord film-coated tablets Ginkgo dry extract TR 1242/1/1 TR holder Pharma Nord ApS March 2018
More informationCHAPTER 4 POST-MARKETING SURVEILLANCE OF DRUGS
CHAPTER 4 POST-MARKETING SURVEILLANCE OF DRUGS Post-marketing surveillance (PMS) to assure the quality, efficacy and safety of drugs after they go on the market and to establish proper methods of use of
More informationLEAF Marque Assurance Programme
Invisible ISEAL Code It is important that the integrity of the LEAF Marque Standard is upheld therefore the LEAF Marque Standards System has an Assurance Programme to ensure this. This document outlines
More informationIMPLEMENTATION COURSE (MODULE 1) (ISO 45001:2016 AVAILABLE ON REQUEST) COURSE DURATION: 3 DAYS FOR OHSAS 18001:2007 OR ISO 45001:2016
OHSAS 18001:2007 IMPLEMENTATION COURSE (MODULE 1) (ISO 45001:2016 AVAILABLE ON REQUEST) COURSE DURATION: 3 DAYS FOR OHSAS 18001:2007 OR ISO 45001:2016 Course Summary: The implementation course provides
More information040716_ANDI_VENTIS WEBSITE(new) Printout 1. HOME PAGE. Welcome to our world of Dry Powder Inhalers!
1. HOME PAGE Welcome to our world of Dry Powder Inhalers! Andi-Ventis Ltd, established in 2001 is a joint venture between Medochemie Ltd, Cyprus and Miat SpA Italy, founded to carry out the pharmaceutical
More informationWe get your personal data from the following sources (examples detailed below are not exhaustive):
Novo Nordisk Limited processes (e.g. collects, uses, stores, and shares) personal data for different reasons (purpose) and uses a number of legal bases to process that personal data. This Notice explains
More informationBCS: Dissolution Testing as a Surrogate for BE Studies
BCS: Dissolution Testing as a Surrogate for BE Studies Dirk M Barends National Institute of Public Health and the Environment The Netherlands APV / IKEV Seminar on Bioavailability and Bioequivalence, Istanbul,
More informationBiomanufacturing Training and Education Center (BTEC) s International Influenza Vaccine Manufacturing Training Program
Biomanufacturing Training and Education Center (BTEC) s International Influenza Vaccine Manufacturing Training Program 5 th Meeting with International Partners on Prospects for Influenza Vaccine Manufacturing
More informationPFC Industry Courses and Certifications
PFC Industry Courses and Certifications Americans for Safe Access (ASA) has been a trusted source of cannabis education and training for over 15 years. As a leader in medical cannabis education since 2002,
More informationWorkshop for OIE national Focal Points for Veterinary Products November 2010, Johannesburg, South Africa. Presentation
Dr. Anja Holm Chair of CVMP, EMA Danish Medicines Agency Copenhagen, DK - Denmark anh@dkma.dk Overview of existing structures relevant for Veterinary Products Regional Structures: Europe European Medicine
More informationEVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL TEXTS FOR USE IN THE ICH REGIONS ON DISINTEGRATION TEST GENERAL CHAPTER Q4B ANNEX 5(R1)
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL
More informationPlanning For The FDA s 'Deeming Rule' For E- Cigarettes
Law360, New York (September 21, 2015, 3:39 PM ET) -- The 2009 Family Smoking Prevention and Tobacco Control Act (TCA)[1] gave the U.S. Food and Drug Administration the authority to oversee the manufacture,
More informationIntroducing BSI. BSI Medical Device Regulatory Update Galway, Ireland. Dr. Michael Weissig EMEA Vice President Healthcare 26 June, 2015
Introducing BSI BSI Medical Device Regulatory Update Galway, Ireland Dr. Michael Weissig EMEA Vice President Healthcare 26 June, 2015 Copyright 2014 BSI. All rights reserved. Global Healthcare Mission
More informationBoehringer Ingelheim Biopharmaceuticals in China. Your Reliable Contract Manufacturing Solution Provider
Boehringer Ingelheim Biopharmaceuticals in China Your Reliable Contract Manufacturing Solution Provider Dr. Bin Wang, Dr. Axel Schleyer Boehringer Ingelheim Biopharmaceuticals (China) Co., Ltd. Contact:
More informationQuality Assurance Standard. Implemented 1991 Revised Version 3.0
Implemented 1991 Revised 2006 Version 3.0 IQPP Contents I. Introduction... 3 II. Definitions... 4 III. PPTA Source Quality Assurance Principles... 4 IV. Audits and Compliance Verification... 5 Page 2 IQPP
More informationICH Q8 & Q9. Presented by John Montalto 13 May, 2013
ICH Q8 & Q9 Presented by John Montalto 13 May, 2013 Guidelines Please contribute Please stopme to ask a question Please relax and enjoy yourself Phone on silent Slide 2 PharmOut 2013 ICH Q8 01 Introduction
More informationWelcome to presentation By Sanjay Punjabi Lead Auditor for ISO 9001, ISO 14001, OHSAS & BS 7799
Welcome to presentation By Sanjay Punjabi Lead Auditor for ISO 9001, ISO 14001, OHSAS 18001 & BS 7799 NETPECKERS CONSULTING (P) LTD. An ISO 9001:2000 compliant organization On Advantages, importance &
More informationQuestions and answers for the March 2009 PQG QP Meeting
Questions and answers for the March 2009 PQG QP Meeting 1.1 5 Micro Control for Non-Sterile Pharmaceuticals 2.1 15 Contract Manufacture We manufacturer dry powders for inhalation in clinical trials. Currently
More informationEnsuring the gap between science and practice is filled safely - MHRA
Safeguarding public health Ensuring the gap between science and practice is filled safely - MHRA Diane Leakey Head of Information and Communications, MHRA April 2012 Agenda Who is MHRA? Why we have regulation?
More informationWE VE GOT THE POWDER THE KEY TO YOUR NEW MEDICATED CHEWING GUM
WE VE GOT THE POWDER THE KEY TO YOUR NEW MEDICATED CHEWING GUM Health in Gum is a powdered excipient specially designed to formulate and produce medicated chewing gum It combines gum base and sweeteners
More informationMHRA Pharmacovigilance System Master File (PSMF) Inspection Findings
MHRA Pharmacovigilance System Master File (PSMF) Inspection Findings Gretel Sakyi Medical Information and Patient Safety Manager AstraZeneca UK 07 June 2018 Agenda MHRA inspections How inspectors use the
More informationQ&A for submission of applications for prequalification of Zinc Sulfate tablets and Zinc Sulfate oral liquid (solution)
Q&A for submission of applications for prequalification of Zinc Sulfate tablets and Zinc Sulfate oral liquid (solution) This document should not be treated as a comprehensive guideline; it serves as a
More information(Adopted by the Committee of Ministers on 19 January 2011 at the 1103rd meeting of the Ministers Deputies)
Resolution CM/ResAP(2011)1 on quality and safety assurance requirements for medicinal products prepared in pharmacies for the special needs of patients (Adopted by the Committee of Ministers on 19 January
More informationWork plan for the joint CHMP/ CVMP Quality Working Party (QWP) for 2018
4 December 2017 EMA/CHMP/CVMP/QWP/504882/2017 Committee for Medicinal Products for Human Use (CHMP) Committee for Medicinal Products for Veterinary Use (CVMP) Work plan for the joint CHMP/ CVMP Quality
More informationCOMPETENT AUTHORITY (UK) MEDICAL DEVICES DIRECTIVES GUIDANCE NOTES FOR MANUFACTURERS OF DENTAL APPLIANCES
COMPETENT AUTHORITY (UK) 10 EC MEDICAL DEVICES DIRECTIVES GUIDANCE NOTES FOR MANUFACTURERS OF DENTAL APPLIANCES (CUSTOM MADE DEVICES) Updated March 2008 CONTENTS PAGE Introduction 3 Definition of dental
More informationEUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union
EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Brussels, 01 September 2008 EudraLex The Rules Governing Medicinal Products in the European Union Volume 4
More informationPublic Assessment Report for a Traditional Herbal Medicinal Product for Human Use
IPAR Public Assessment Report for a Traditional Herbal Medicinal Product for Human Use Agnus castus oral drops Tincture of Agnus castus fruit TR2309/017/001 A. Vogel Ireland Limited 28 November 2018 CRN008R68
More informationMedidée Services SA. Nano-Tera.ch. 05 February 2015 part 4. Intro ISO GMP - GLP Pierre-Alain Sommer
Nano-Tera.ch 05 February 2015 part 4 Intro ISO GMP - GLP Pierre-Alain Sommer Pierre-alain.sommer@medidee.com www.medidee.com Nano-Tera 2015 05.02.2015 Introduction to ISO 13485, cgmp s and GLP s Context
More informationPublic Training Program. ENVIRONMENTAL MANAGEMENT SYSTEM ISO 14001: Lead Auditor Course (IRCA Accredited) (5 Days) Oct 2011 (Abu Dhabi)
Public Training Program ENVIRONMENTAL MANAGEMENT SYSTEM ISO 14001:2004 - Lead Auditor Course (IRCA Accredited) (5 Days) 23-27 Oct 2011 (Abu Dhabi) 20 24 Nov 2011 (Dubai) 11 15 Dec 2011 (Abu Dhabi) Fee:
More informationProduct Information Sheet MALTOSWEET
Contents: 1. Supplier Information 2. Emergency Contacts 3. Product Information 4. Regulatory Status 5. Ingredient Statement 6. Quality Documents 7. Kosher/Halal Status 8. Allergen Status 9. Sulfur Dioxide
More informationProduct Information Sheet RESISTAMYL
Contents: 1. Supplier Information 2. Emergency Contacts 3. Product Information 4. Regulatory Status 5. Ingredient Statement 6. Quality Documents 7. Kosher/Halal Status 8. Allergen Status 9. Sulfur Dioxide
More informationREGULATORY CHALLENGES IN SOUTH AFRICA
REGULATORY CHALLENGES IN SOUTH AFRICA MEDICINES CONTROL COUNCIL SA Prof Peter Eagles Chairperson Medicines Control Council [Southern African Regional and International Symposium (SARI 2014)] 1 OUTLINE
More informationPublic Assessment Report for a Traditional Herbal Medicinal Product for Human Use
IPAR Public Assessment Report for a Traditional Herbal Medicinal Product for Human Use Ginkgoforce Memory & Circulation Ginkgo Tablets Extract (as dry extract) from fresh leaves of Ginkgo biloba (Ginkgo
More informationMANUFACTURER OF HIGH PURITY SPECIALTY CHEMICALS
The IPEC Excipient Stability Program Guide 2010 MANUFACTURER OF HIGH PURITY SPECIALTY CHEMICALS For the, nutraceutical, pharmaceutical, food & other specialty markets 1 Jost Chemical Founded by Jerry Jost
More informationCDER Compliance Update
CDER Compliance Update Donald D. Ashley, JD 22 nd Annual GMP by the Sea August 30, 2017 www.fda.gov www.fda.gov 2 Office of Compliance Structure Office of Compliance Office of Drug Security, Integrity
More informationProduct Information Sheet MERIZET
Contents: 1. Supplier Information 2. Emergency Contacts 3. Product Information 4. Regulatory Status 5. Ingredient Statement 6. Quality Documents 7. Kosher/Halal Status 8. Allergen Status 9. Sulfur Dioxide
More informationFood Commissaries under FSMA and the US FDA model Food Code
Food Commissaries under FSMA and the US FDA model Food Code Introduction A food commissary is a facility or operation that procures and/or produces foods intended for distribution. A retail or foodservice
More informationPublic Assessment Report for a Traditional Herbal Medicinal Product for Human Use
IPAR Public Assessment Report for a Traditional Herbal Medicinal Product for Human Use Venaforce Varicose Veins gastro-resistant tablets Dry extract from fresh Aesculus hippocastanum L., semen (Horse Chestnut
More informationBuilding a Strong Quality Culture
Building a Strong Quality Culture Alicia Mozzachio, RPh, MPH Senior Advisor for International Activities Office of Policy for Pharmaceutical Quality Office of Pharmaceutical Quality 1 Agenda Changing an
More informationJOB SPECIFICATION FORM NO: HR-SOP Environment, Health & Safety Manager. Overview and Job purpose
JOB SPECIFICATION Job Title: Reporting To: Function: Job Location: Environment, Health & Safety Manager Head of QEHS, Technical & Blends QEHS, Technical & Blends Coleford Overview and Job purpose Direct
More informationThe Soft Gel Specialist
Renown PHARMACEUTICALS PVT. LTD. The Soft Gel Specialist Prestigious History Welcome to Renown Pharmaceuticals Demand for Soft Gelatin Capsules is ever increasing for Nutraceuticals, Cosmetics and Herbals.
More informationFEES IN SGD. Quality Annex SL Module 1 Transition Course Quality ISO 9001:2015 Module 2 Transition Course
ISO 9001:2015 Management Systems ISO 9001:2015 Management Systems ISO 9001:2015 Management Systems ISO 9001:2015 Management Systems Transition 1 380 17 17 18 23 16 14 2 760 17 18 17 18 18 19 23 24 16 17
More informationDecentralised Procedure. Public Assessment Report
Bundesinstitut für Arzneimittel und Medizinprodukte Decentralised Procedure Public Assessment Report Clozapin Regiomedica 50 mg/ml Suspension zum Einnehmen Clozamedica 50 mg/ml Suspension zum Einnehmen
More informationTown and Country Compounding and Consultation Services, LLC 10/17/17
Town and Country Compounding and Consultation Services, LLC 10/17/17 Division of Pharmaceutical Quality Operations I 10 Waterview Blvd, 3rd FL Parsippany, NJ 07054 Telephone: (973) 331-4900 FAX: (973)
More informationa practical guide ISO 13485:2016 Medical devices Advice from ISO/TC 210
a practical guide ISO 13485:2016 Medical devices Advice from ISO/TC 210 for SMEs a practical guide ISO 13485:2016 Medical devices Advice from ISO/TC 210 Copyright protected document All rights reserved.
More informationInspections, Compliance, Enforcement, and Criminal Investigations. Central Texas Regional Blood & Tissue Center 07-Nov-03
1 of 7 6/10/2009 2:20 PM Inspections, Compliance, Enforcement, and Criminal Investigations Department of Health and Human Services Public Health Service Food and Drug Administration Dallas District 4040
More informationPoints to Consider CPhI Japan Briefing Session on Pharmaceutical Regulations in Japan
2013 CPhI Japan Briefing Session on Pharmaceutical Regulations in Japan The Master File System and Points to Consider Kentaro Hashimoto, Master File Management Group, Division of Pharmacopoeia and Standards
More informationProduct Information Sheet CLARIA Elite
Contents: 1. Supplier Information 2. Emergency Contacts 3. Product Information 4. Regulatory Status 5. Ingredient Statement 6. Quality Documents 7. Kosher/Halal Status 8. Allergen Status 9. Sulfur Dioxide
More informationGLOBAL BIOANALYSIS CONSORTIUM
GLOBAL BIOANALYSIS CONSORTIUM Scope and Regulations Harmonization Team: A1 (Work in Progress) John Smeraglia on behalf of the HT-A1 A1: Scope and regulations Team members: Team lead Region Expertise Surendra
More informationOverview of Dietary Supplement GMP Inspection Trends Quality Session 6
Overview of Dietary Supplement GMP Inspection Trends Quality Session 6 Presented by: Dean R. Cirotta, MBA President & Chief Operating Officer EAS Consulting Group, LLC 1700 Diagonal Road, Suite 750 Alexandria,
More informationExpectations for Implementation in Europe
Expectations for Implementation in Europe Henk de Jong IPEC Federation Observer Q3D EWG PQRI/USP Workshop 3/31 & 4/1 2015 ICH Q3D is here CHMP (committee for Medicinal Products for Human Use) approved
More informationGuide to Registration of Homeopathic Veterinary Medicinal Products
Guide to Registration of Homeopathic Veterinary Medicinal Products AUT-G0047-3 16 NOVEMBER 2012 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes
More informationGMP IN BLOOD ESTABLISHMENTS: A BASIC ELEMENT FOR PLASMA QUALITY
GMP IN BLOOD ESTABLISHMENTS: A BASIC ELEMENT FOR PLASMA QUALITY Dr. Christian Schärer Swissmedic, Swiss Agency for Therapeutic Products Inspectorates, Hallerstrasse 7 CH-3000 Bern 9 christian.schaerer@swissmedic.ch
More informationAllergen Cleaning, Verification & Validation
Allergen Cleaning, Verification & Validation Dan Schmitz Director of Operations Commercial Food Sanitation An Intralox company Strategic consulting Training and education Providing durable solutions to
More informationTable 1 Model of STRIDESMOOTH (Stride) and STRIDESMOOTH+ Microcatheter
AMM-Q269 Ver.7 Page 2 of 5 Table 1 Model of STRIDESMOOTH (Stride) and STRIDESMOOTH+ Microcatheter Product name STRIDESMOOTH (Stride) Model No. STD105-22S STD125-22S STD125-22A STD130-22S STD150-22S STD105-26S
More informationNew Annex 15 Updated Requirements & Approach to Validation. Presented by Ashley Isbel 10 th August 2015
New Annex 15 Updated Requirements & Approach to Validation Presented by Ashley Isbel 10 th August 2015 EU GMP Guide Annex 15 Qualification & Validation 2001 Current version of Annex 15 published Nov 2012
More informationMemree. Supports Cognitive Function and Stress Reduction. Memree. Nutrition
Nutrition Memree Supports Cognitive Function and Stress Reduction Memree for Human Nutrition English Memree Memree contains high-quality soy phosphatidylserine and is a trademark of Lonza Ltd, Switzerland.
More informationAGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION. (Moscow, 23 December 2014)
AGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION (Moscow, 23 December 2014) Member States of the Eurasian Economic Union, hereinafter referred
More informationDIRECTIVES. (Text with EEA relevance)
L 238/44 DIRECTIVES COMMISSION DIRECTIVE (EU) 2017/1572 of 15 September 2017 supplementing Directive 2001/83/EC of the European Parliament and of the Council as regards the principles and guidelines of
More informationContamination & Cross-contamination best practices New EU & PIC/S requirements. Presented by Gordon Farquharson August 2015
Contamination & Cross-contamination best practices New EU & PIC/S requirements Presented by Gordon Farquharson August 2015 Where and why did all this begin? It all began in 2005, 10 years ago! First we
More informationTechnology and Quality of Inhalation Drug Products
Technology and Quality of Inhalation Drug Products Good Development Practices, Specifications, and Analytical Methods for Metered Dose Inhaler (MDI) and Dry Powder Inhaler (DPI) Respiratory Drugs 5 6 November
More informationBoehringer Ingelheim BioXcellence. Producing Value. Global Contract Manufacturing Excellence
Boehringer Ingelheim BioXcellence Producing Value Global Contract Manufacturing Excellence Your World Class Contract Manufacturer Boehringer Ingelheim BioXcellence Producing Value Boehringer Ingelheim
More informationIso Audit Checklist
We have made it easy for you to find a PDF Ebooks without any digging. And by having access to our ebooks online or by storing it on your computer, you have convenient answers with iso 13485 audit checklist.
More informationTGA regulation of local manufacturers of plasma derivatives CSL Behring Australia s overview
IPFA Workshop Session 7: REGULATORY CONSIDERATIONS TGA regulation of local manufacturers of plasma derivatives CSL Behring Australia s overview Mary Lavithis, CSL Behring Australia Presented at: IPFA Asia
More informationa practical guide Medical Devices Advice from ISO/TC 210 This is a free 11 page sample. Access the full version online.
NSAI/ISO Guide to ISO 13485:2016 Medical Devices a practical guide Advice from ISO/TC 210 NSAI/ISO Guide to ISO 13485:2016 This Guide is the NSAI adoption of and is technically identical to the English
More information